Efflux pump gene expression in multidrug-resistant Mycobacterium tuberculosis clinical isolates

PLoS ONE

Volumn 10, Issue 2, 2015, Pages

  Li, Guilian ^a,b   Zhang, Jingrui ^a,b,c,d   Guo, Qian ^a,b,e   Jiang, Yi ^a,b   Wei, Jianhao ^a,b,c   Zhao, Li Li ^a,b   Zhao, Xiuqin ^a,b   Lu, Jianxin ^c   Wan, Kanglin ^a,b  

^a National Institute for Communicable Diseases Prevention and Control   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c WENZHOU MEDICAL UNIVERSITY   (China)

^d Laboratory Shijiazhuang Gynecological and Obstetric Hospital   (China)

^e UNIVERSITY OF SOUTH CHINA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CAPREOMYCIN; CARBONYL CYANIDE CHLOROPHENYLHYDRAZONE; ETHAMBUTOL; ISONIAZID; KANAMYCIN; OFLOXACIN; RESERPINE; RIFAMPICIN; STREPTOMYCIN; BACTERIAL PROTEIN; CARRIER PROTEIN; DNA BINDING PROTEIN; DRRA PROTEIN, BACTERIA; QACA PROTEIN, STAPHYLOCOCCUS AUREUS;

ARTICLE; BACTERIAL GENE; CONTROLLED STUDY; DRRA GENE; DRRB GENE; EFPA GENE; GENE DELETION; GENE FUNCTION; GENE INDUCTION; GENE OVEREXPRESSION; INHA GENE; JEFA GENE; KATG GENE; MINIMUM INHIBITORY CONCENTRATION; MMR GENE; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OXYR AHPC GENE; RPOB GENE; RV0849 GENE; RV1250 GENE; UPREGULATION; ANTIBIOTIC RESISTANCE; DRUG EFFECTS; GENE; GENETICS; METABOLISM;

MYCOBACTERIUM TUBERCULOSIS;

BACTERIAL PROTEINS; DNA-BINDING PROTEINS; DRUG RESISTANCE, BACTERIAL; GENES, MDR; MEMBRANE TRANSPORT PROTEINS; MYCOBACTERIUM TUBERCULOSIS; UP-REGULATION;

EID: 84923172428     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0119013     Document Type: Article

References (45)

1. McCammon MT, Gillette JS, Thomas DP, Ramaswamy SV, Graviss EA, Kreiswirth BN, et al. Detection of rpoB mutations associated with rifampin resistance in Mycobacterium tuberculosis using denaturing gradient gel electrophoresis. Antimicrob Agents Chemother. 2005; 49: 2200-2209. PMID: 15917513
2. Doustdar F, Khosravi AD, Farnia P, Masjedi MR, Velayati AA. Molecular analysis of isoniazid resistance in different genotypes of Mycobacterium tuberculosis isolates from Iran. Microb Drug Resist. 2008; 14: 273-279. doi: 10.1089/mdr.2008.0842 PMID: 19090721
3. Aslan G, Tezcan S, Serin MS, Emekdas G. Genotypic analysis of isoniazid and rifampin resistance in drug-resistant clinical Mycobacterium tuberculosis complex isolates in southern Turkey. Jpn J Infect Dis. 2008; 61: 255-260. PMID: 18653964
4. Sekiguchi J, Miyoshi-Akiyama T, Augustynowicz-Kopec E, Zwolska Z, Kirikae F, Toyota E, et al. Detection of multidrug resistance in Mycobacterium tuberculosis. J Clin Microbiol. 2007; 45: 179-192. PMID: 17108078
5. Mukaigawa J, Endoh M, Yanagawa Y, Morozumi S. Anti-drug pattern of drug-resistant Mycobacterium tuberculosis and analysis of mutation in drug-target genes. Kansenshogaku Zasshi. 2005; 79: 388-396. PMID: 16022476
6. Kiepiela P, Bishop KS, Smith AN, Roux L, York DF. Genomic mutations in the katG, inhA and aphC genes are useful for the prediction of isoniazid resistance in Mycobacterium tuberculosis isolates from Kwazulu Natal, South Africa. Tuber Lung Dis. 2000; 80: 47-56. PMID: 10897383
7. Banerjee A, Sugantino M, Sacchettini JC, Jacobs WR Jr. The mabA gene from the inhA operon of Mycobacterium tuberculosis encodes a 3-ketoacyl reductase that fails to confer isoniazid resistance. Microbiology. 1998; 144 (Pt 10): 2697-2704.
8. Mokrousov I, Narvskaya O, Otten T, Limeschenko E, Steklova L, Vyshnevskiy B. High prevalence of KatG Ser315Thr substitution among isoniazid-resistant Mycobacterium tuberculosis clinical isolates from northwestern Russia, 1996 to 2001. Antimicrob Agents Chemother. 2002; 46: 1417-1424. PMID: 11959577
9. Niederweis M. Mycobacterial porins-new channel proteins in unique outer membranes. Mol Microbiol. 2003; 49: 1167-1177. PMID: 12940978
10. Brennan PJ. Structure, function, and biogenesis of the cell wall of Mycobacterium tuberculosis. Tuberculosis (Edinb). 2003; 83: 91-97. PMID: 12758196
11. Choudhuri BS, Bhakta S, Barik R, Basu J, Kundu M, Chakrabarti P. Overexpression and functional characterization of an ABC (ATP-binding cassette) transporter encoded by the genes drrA and drrB of Mycobacterium tuberculosis. Biochem J. 2002; 367: 279-285. PMID: 12057006
12. Balganesh M, Kuruppath S, Marcel N, Sharma S, Nair A, Sharma U. Rv1218c, an ABC transporter of Mycobacterium tuberculosis with implications in drug discovery. Antimicrob Agents Chemother. 2010; 54: 5167-5172. doi: 10.1128/AAC.00610-10 PMID: 20921309
13. Ramon-Garcia S, Martin C, Thompson CJ, Ainsa JA. Role of the Mycobacterium tuberculosis P55 efflux pump in intrinsic drug resistance, oxidative stress responses, and growth. Antimicrob Agents Chemother. 2009; 53: 3675-3682. doi: 10.1128/AAC.00550-09 PMID: 19564371
14. Pasca MR, Guglierame P, De Rossi E, Zara F, Riccardi G. mmpL7 gene of Mycobacterium tuberculosis is responsible for isoniazid efflux in Mycobacterium smegmatis. Antimicrob Agents Chemother. 2005; 49: 4775-4777. PMID: 16251328
15. Jiang X, Zhang W, Zhang Y, Gao F, Lu C, Zhang X, et al. Assessment of efflux pump gene expression in a clinical isolate Mycobacterium tuberculosis by real-time reverse transcription PCR. Microb Drug Resist. 2008; 14: 7-11. doi: 10.1089/mdr.2008.0772 PMID: 18321205
16. Gupta AK, Katoch VM, Chauhan DS, Sharma R, Singh M, Venkatesan K, et al. Microarray analysis of efflux pump genes in multidrug-resistant Mycobacterium tuberculosis during stress induced by common anti-tuberculous drugs. Microb Drug Resist. 2010; 16: 21-28. doi: 10.1089/mdr.2009.0054 PMID: 20001742
17. Gupta AK, Reddy VP, Lavania M, Chauhan DS, Venkatesan K, Sharma VD, et al. jefA (Rv2459), a drug efflux gene in Mycobacterium tuberculosis confers resistance to isoniazid & ethambutol. Indian J Med Res. 2010; 132: 176-188. PMID: 20716818
18. Piddock LJ, Williams KJ, Ricci V. Accumulation of rifampicin by Mycobacterium aurum, Mycobacterium smegmatis and Mycobacterium tuberculosis. J Antimicrob Chemother. 2000; 45: 159-165. PMID: 10660497
19. Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature. 1998; 393: 537-544. PMID: 9634230
20. Pang Y, Lu J, Wang Y, Song Y, Wang S, Zhao Y. Study of the rifampin monoresistance mechanism in Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2013; 57: 893-900. doi: 10.1128/AAC.01024-12 PMID: 23208715
21. Kamerbeek J, Schouls L, Kolk A, van Agterveld M, van Soolingen D, Kuijper S, et al. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol. 1997; 35: 907-914. PMID: 9157152
22. World Health Organization Policy guidance on drug-susceptibility testing (DST) of second-line antituberculosis drugs (WHO/HTM/TB/2008.392). World Health Organization, Geneva, 2008.
23. World Health Organization. 2012 Updated critical concentrations for first-line and second-line DST (as of May 2012).
24. Leonard B, Coronel J, Siedner M, Grandjean L, Caviedes L, Navarro P, et al. Inter- and intra-assay reproducibility of microplate Alamar blue assay results for isoniazid, rifampicin, ethambutol, streptomycin, ciprofloxacin, and capreomycin drug susceptibility testing of Mycobacterium tuberculosis. J Clin Microbiol. 2008; 46: 3526-3529. doi: 10.1128/JCM.02083-07 PMID: 18701659
25. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001; 25: 402-408. PMID: 11846609
26. DeMarco CE, Cushing LA, Frempong-Manso E, Seo SM, Jaravaza TA, Kaatz GW. Efflux-related resistance to norfloxacin, dyes, and biocides in bloodstream isolates of Staphylococcus aureus. Antimicrob Agents Chemother. 2007; 51: 3235-3239. PMID: 17576828
27. Rodrigues L, Machado D, Couto I, Amaral L, Viveiros M. Contribution of efflux activity to isoniazid resistance in the Mycobacterium tuberculosis complex. Infect Genet Evol. 2011; 12: 695-700. doi: 10.1016/j.meegid.2011.08.009 PMID: 21871582
28. Bustin SA, Beaulieu JF, Huggett J, Jaggi R, Kibenge FS, Olsvik PA, et al. MIQE precis: Practical implementation of minimum standard guidelines for fluorescence-based quantitative real-time PCR experiments. BMC Mol Biol. 2010; 11: 74. doi: 10.1186/1471-2199-11-74 PMID: 20858237
29. Escribano I, Rodriguez JC, Llorca B, Garcia-Pachon E, Ruiz M, Royo G. Importance of the efflux pump systems in the resistance of Mycobacterium tuberculosis to fluoroquinolones and linezolid. Chemotherapy. 2007; 53: 397-401. PMID: 17934259
30. Louw GE, Warren RM, Gey van Pittius NC, Leon R, Jimenez A, Hernandez-Pando R, et al. Rifampicin reduces susceptibility to ofloxacin in rifampicin-resistant Mycobacterium tuberculosis through efflux. Am J Respir Crit Care Med. 2011; 184: 269-276. doi: 10.1164/rccm.201011-1924OC PMID: 21512166
31. Fu LM. Exploring drug action on Mycobacterium tuberculosis using affymetrix oligonucleotide genechips. Tuberculosis (Edinb). 2006; 86: 134-143. PMID: 16246625
32. Betts JC, McLaren A, Lennon MG, Kelly FM, Lukey PT, Blakemore SJ, et al. Signature gene expression profiles discriminate between isoniazid-, thiolactomycin-, and triclosan-treated Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2003; 47: 2903-2913. PMID: 12936993
33. Waddell SJ, Stabler RA, Laing K, Kremer L, Reynolds RC, Besra GS. The use of microarray analysis to determine the gene expression profiles of Mycobacterium tuberculosis in response to anti-bacterial compounds. Tuberculosis (Edinb). 2004; 84: 263-274. PMID: 15207496
34. Balganesh M, Dinesh N, Sharma S, Kuruppath S, Nair AV, Sharma U. Efflux pumps of Mycobacterium tuberculosis play a significant role in antituberculosis activity of potential drug candidates. Antimicrob Agents Chemother. 2012; 56: 2643-2651. doi: 10.1128/AAC.06003-11 PMID: 22314527
35. De Rossi E, Branzoni M, Cantoni R, Milano A, Riccardi G, Ciferri O. mmr, a Mycobacterium tuberculosis gene conferring resistance to small cationic dyes and inhibitors. J Bacteriol. 1998; 180: 6068-6071. PMID: 9811672
36. De Rossi E, Arrigo P, Bellinzoni M, Silva PA, Martin C, Ainsa JA, et al. The multidrug transporters belonging to major facilitator superfamily in Mycobacterium tuberculosis. Mol Med. 2002; 8: 714-724. PMID: 12520088
37. De Rossi E, Ainsa JA, Riccardi G. Role of mycobacterial efflux transporters in drug resistance: an unresolved question. FEMS Microbiol Rev. 2006; 30: 36-52. PMID: 16438679
38. Li XZ, Zhang L, Nikaido H. Efflux pump-mediated intrinsic drug resistance in Mycobacterium smegmatis. Antimicrob Agents Chemother. 2004; 48: 2415-2423. PMID: 15215089
39. Zhang Y, Heym B, Allen B, Young D, Cole S. The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature. 1992; 358: 591-593. PMID: 1501713
40. Sacchettini JC, Blanchard JS. The structure and function of the isoniazid target in M. tuberculosis. Res Microbiol. 1996; 147: 36-43. PMID: 8761720
41. Somoskovi A, Parsons LM, Salfinger M. The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis. Respir Res. 2001; 2: 164-168. PMID: 11686881
42. McClure WR, Cech CL. On the mechanism of rifampicin inhibition of RNA synthesis. J Biol Chem. 1978; 253: 8949-8956. PMID: 363713
43. Camus JC, Pryor MJ, Medigue C, Cole ST. Re-annotation of the genome sequence of Mycobacterium tuberculosis H37Rv. Microbiology. 2002; 148: 2967-2973. PMID: 12368430
44. Zhang JR, Li GL, Zhao XQ, Wan KL, Lu JX. [A primary investigation on the isoniazid-induced alterations in efflux gene expression among the isoniazid resistant Mycobacterium tuberculosis clinical isolates]. Zhonghua Liu Xing Bing Xue Za Zhi. 2013; 34: 379-384. PMID: 23937845
45. da Silva PE, Von Groll A, Martin A, Palomino JC. Efflux as a mechanism for drug resistance in Mycobacterium tuberculosis. FEMS Immunol Med Microbiol. 2011; 63: 1-9. doi: 10.1111/j.1574-695X.2011.00831.x PMID: 21668514